Latest Form 4 insider transactions

Brian Hongdi Gu, Vice Chairman & Co-President of Xpeng Inc., reported multiple transactions in common stock on October 2, 2026.

Chandan Basho, COO and CFO of Astrana Health, Inc., reported a transaction in 2,092 shares of common stock on October 2, 2026.

Hudson Blake Leogrande, a Director of Prenetics Global Ltd, reported multiple transactions in common stock on October 4, 2026.

Theodore Zhu, a Director of Predictive Oncology Inc., received 733 shares of common stock on October 1, 2026.

Charles Lee Nuzum Sr, a Director of Predictive Oncology Inc., received 733 shares of common stock on October 1, 2026.

Matthew Hawryluk, a Director of Predictive Oncology Inc., received 733 shares of common stock on October 1, 2026.

Daniel E Handley, a Director of Predictive Oncology Inc., received 528 shares of common stock on October 1, 2026.

Thorsten Dirks, a Director of Predictive Oncology Inc., reported multiple transactions in common stock on April 20, 2026.

Clair Gregory St. Sr, a Director of Predictive Oncology Inc., received 733 shares of common stock on October 1, 2026.

Anthony Michael Denier, President and a Director of Webull Corp, sold 53,846 shares of common stock on October 5, 2026 for $7.33 per share.

Benjamin Pham, Chief Financial Officer and a Director of Asset Entities Inc., sold 4,209 shares of common stock on October 5, 2026 for $31.33 per share.

Matthew Ryan Cole, Chief Executive Officer and a Director of Asset Entities Inc., sold 58,789 shares of common stock on October 5, 2026 for $31.33 per share.

Jonathan R Macey, a Director of Asset Entities Inc., sold 6,700 shares of common stock on October 5, 2026 for $30.32 per share.

C.H. Robinson announced its acquisition of RXO, aiming to create a more comprehensive logistics platform and unlock significant shareholder value.

C.H. Robinson announced its acquisition of RXO, aiming to create a more comprehensive logistics platform and unlock significant shareholder value.

James Lavish, a Director of Asset Entities Inc., sold 6,000 shares of common stock on October 5, 2026 for $30.75 per share.

Brian Logan Beirne, Chief Legal Officer and a Director of Asset Entities Inc., sold 20,077 shares of common stock on October 5, 2026 for $31.33 per share.

Arshia Sarkhani, Chief Marketing Officer and a Director of Asset Entities Inc., sold 5,634 shares of common stock on October 5, 2026 for $31.33 per share.

Wolfe Repass, Chief Financial Officer of FTAC Emerald Acquisition Corp., sold 1,231 shares of common stock on October 1, 2026 for $0.53 per share.

William Brian Poppic Reeves, Chief Executive Officer and 10% owner of FTAC Emerald Acquisition Corp., sold 5,304 shares of common stock on October 1, 2026 for $0.53 per share.

Thomas J Dickman, Chief Technology Officer of FTAC Emerald Acquisition Corp., sold 6 shares of common stock on October 1, 2026 for $0.53 per share.

Vyacheslav Kim, a Director of Joint Stock Co Kaspi.kz, sold 71,368 shares of common stock on October 1, 2026.

Charles Kane, a Director of Symbotic Inc., sold 2,000 shares of common stock on October 1, 2026.

Azure Energy, Llc reported changes in beneficial ownership of Algorhythm Holdings, Inc. common stock on September 15, 2026.

Andrew Little Thompson, CEO and a Director of Algorhythm Holdings, Inc., purchased 4,098,350 shares of common stock on September 15, 2026.

Ryan A Benton, Interim CEO of Enovix Corp, reported a transaction in 10,988 shares of common stock on October 1, 2026.

Kristina Truong, Chief Accounting Officer of Enovix Corp, reported multiple transactions in common stock on October 1, 2026.

Arthi Chakravarthy, Chief Legal Officer of Enovix Corp, reported multiple transactions in common stock on October 1, 2026.

Berkshire Hathaway Inc and 1 other reported changes in beneficial ownership of Lennar Corp /New/ common stock on October 1, 2026.

Berkshire Hathaway Inc and 1 other reported changes in beneficial ownership of Berkshire Hathaway Inc common stock on October 1, 2026.